For instance, NPY promotes breast cancer metastasis by stimulating endothelial cell migration via Y2 receptors, while SP enhances pancreatic cancer proliferation by activating neurokinin-1 receptor (NK1R)-mediated ERK signaling. Here, TACR1 is linked to breast carcinoma.